Pharmaceutical Drugs and Natural Therapeutic Products for the Treatment of Type 2 Diabetes Mellitus

Type 2 diabetes mellitus (T2DM) is the most widespread form of diabetes, characterized by chronic hyperglycaemia, insulin resistance, and inefficient insulin secretion and action. Primary care in T2DM is pharmacological, using drugs of several groups that include insulin sensitisers (e.g., biguanide...

Full description

Bibliographic Details
Main Authors: Jana Blahova, Monika Martiniakova, Martina Babikova, Veronika Kovacova, Vladimira Mondockova, Radoslav Omelka
Format: Article
Language:English
Published: MDPI AG 2021-08-01
Series:Pharmaceuticals
Subjects:
Online Access:https://www.mdpi.com/1424-8247/14/8/806
id doaj-9ecfb407f1424f238191079c76bd7fa7
record_format Article
spelling doaj-9ecfb407f1424f238191079c76bd7fa72021-08-26T14:12:28ZengMDPI AGPharmaceuticals1424-82472021-08-011480680610.3390/ph14080806Pharmaceutical Drugs and Natural Therapeutic Products for the Treatment of Type 2 Diabetes MellitusJana Blahova0Monika Martiniakova1Martina Babikova2Veronika Kovacova3Vladimira Mondockova4Radoslav Omelka5Department of Botany and Genetics, Faculty of Natural Sciences, Constantine the Philosopher University in Nitra, 949 74 Nitra, SlovakiaDepartment of Zoology and Anthropology, Faculty of Natural Sciences, Constantine the Philosopher University in Nitra, 949 74 Nitra, SlovakiaDepartment of Botany and Genetics, Faculty of Natural Sciences, Constantine the Philosopher University in Nitra, 949 74 Nitra, SlovakiaDepartment of Zoology and Anthropology, Faculty of Natural Sciences, Constantine the Philosopher University in Nitra, 949 74 Nitra, SlovakiaDepartment of Botany and Genetics, Faculty of Natural Sciences, Constantine the Philosopher University in Nitra, 949 74 Nitra, SlovakiaDepartment of Botany and Genetics, Faculty of Natural Sciences, Constantine the Philosopher University in Nitra, 949 74 Nitra, SlovakiaType 2 diabetes mellitus (T2DM) is the most widespread form of diabetes, characterized by chronic hyperglycaemia, insulin resistance, and inefficient insulin secretion and action. Primary care in T2DM is pharmacological, using drugs of several groups that include insulin sensitisers (e.g., biguanides, thiazolidinediones), insulin secretagogues (e.g., sulphonylureas, meglinides), alpha-glucosidase inhibitors, and the newest incretin-based therapies and sodium–glucose co-transporter 2 inhibitors. However, their long-term application can cause many harmful side effects, emphasising the importance of the using natural therapeutic products. Natural health substances including non-flavonoid polyphenols (e.g., resveratrol, curcumin, tannins, and lignans), flavonoids (e.g., anthocyanins, epigallocatechin gallate, quercetin, naringin, rutin, and kaempferol), plant fruits, vegetables and other products (e.g., garlic, green tea, blackcurrant, rowanberry, bilberry, strawberry, cornelian cherry, olive oil, sesame oil, and carrot) may be a safer alternative to primary pharmacological therapy. They are recommended as food supplements to prevent and/or ameliorate T2DM-related complications. In the advanced stage of T2DM, the combination therapy of synthetic agents and natural compounds with synergistic interactions makes the treatment more efficient. In this review, both pharmaceutical drugs and selected natural products, as well as combination therapies, are characterized. Mechanisms of their action and possible negative side effects are also provided.https://www.mdpi.com/1424-8247/14/8/806type 2 diabetes mellitusmolecular mechanismstreatmentpharmaceutical drugsnatural therapeutic productscombination therapy
collection DOAJ
language English
format Article
sources DOAJ
author Jana Blahova
Monika Martiniakova
Martina Babikova
Veronika Kovacova
Vladimira Mondockova
Radoslav Omelka
spellingShingle Jana Blahova
Monika Martiniakova
Martina Babikova
Veronika Kovacova
Vladimira Mondockova
Radoslav Omelka
Pharmaceutical Drugs and Natural Therapeutic Products for the Treatment of Type 2 Diabetes Mellitus
Pharmaceuticals
type 2 diabetes mellitus
molecular mechanisms
treatment
pharmaceutical drugs
natural therapeutic products
combination therapy
author_facet Jana Blahova
Monika Martiniakova
Martina Babikova
Veronika Kovacova
Vladimira Mondockova
Radoslav Omelka
author_sort Jana Blahova
title Pharmaceutical Drugs and Natural Therapeutic Products for the Treatment of Type 2 Diabetes Mellitus
title_short Pharmaceutical Drugs and Natural Therapeutic Products for the Treatment of Type 2 Diabetes Mellitus
title_full Pharmaceutical Drugs and Natural Therapeutic Products for the Treatment of Type 2 Diabetes Mellitus
title_fullStr Pharmaceutical Drugs and Natural Therapeutic Products for the Treatment of Type 2 Diabetes Mellitus
title_full_unstemmed Pharmaceutical Drugs and Natural Therapeutic Products for the Treatment of Type 2 Diabetes Mellitus
title_sort pharmaceutical drugs and natural therapeutic products for the treatment of type 2 diabetes mellitus
publisher MDPI AG
series Pharmaceuticals
issn 1424-8247
publishDate 2021-08-01
description Type 2 diabetes mellitus (T2DM) is the most widespread form of diabetes, characterized by chronic hyperglycaemia, insulin resistance, and inefficient insulin secretion and action. Primary care in T2DM is pharmacological, using drugs of several groups that include insulin sensitisers (e.g., biguanides, thiazolidinediones), insulin secretagogues (e.g., sulphonylureas, meglinides), alpha-glucosidase inhibitors, and the newest incretin-based therapies and sodium–glucose co-transporter 2 inhibitors. However, their long-term application can cause many harmful side effects, emphasising the importance of the using natural therapeutic products. Natural health substances including non-flavonoid polyphenols (e.g., resveratrol, curcumin, tannins, and lignans), flavonoids (e.g., anthocyanins, epigallocatechin gallate, quercetin, naringin, rutin, and kaempferol), plant fruits, vegetables and other products (e.g., garlic, green tea, blackcurrant, rowanberry, bilberry, strawberry, cornelian cherry, olive oil, sesame oil, and carrot) may be a safer alternative to primary pharmacological therapy. They are recommended as food supplements to prevent and/or ameliorate T2DM-related complications. In the advanced stage of T2DM, the combination therapy of synthetic agents and natural compounds with synergistic interactions makes the treatment more efficient. In this review, both pharmaceutical drugs and selected natural products, as well as combination therapies, are characterized. Mechanisms of their action and possible negative side effects are also provided.
topic type 2 diabetes mellitus
molecular mechanisms
treatment
pharmaceutical drugs
natural therapeutic products
combination therapy
url https://www.mdpi.com/1424-8247/14/8/806
work_keys_str_mv AT janablahova pharmaceuticaldrugsandnaturaltherapeuticproductsforthetreatmentoftype2diabetesmellitus
AT monikamartiniakova pharmaceuticaldrugsandnaturaltherapeuticproductsforthetreatmentoftype2diabetesmellitus
AT martinababikova pharmaceuticaldrugsandnaturaltherapeuticproductsforthetreatmentoftype2diabetesmellitus
AT veronikakovacova pharmaceuticaldrugsandnaturaltherapeuticproductsforthetreatmentoftype2diabetesmellitus
AT vladimiramondockova pharmaceuticaldrugsandnaturaltherapeuticproductsforthetreatmentoftype2diabetesmellitus
AT radoslavomelka pharmaceuticaldrugsandnaturaltherapeuticproductsforthetreatmentoftype2diabetesmellitus
_version_ 1721190769395499008